Lung Adenocarcinoma, Stage I

2

Review clinical trials related to Lung Adenocarcinoma, Stage I. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

The goal of this observational study is to improve the intraoperative diagnosis accuracy of invasiveness for small-sized lung adenocarcinoma by combining multi-modal information. The main question it aims to answer is whether multi-modal information have great value of prediction on the invasiveness for small-sized lung adenocarcinoma. Since a promising limited resection is largely based on intraoperative frozen section diagnosis, there is a growing demand on the high-accuracy of timely pathology diagnosis. The multi-modal information of participants will be collected retrospectively.

Participants needed: 3,000
Trial details
Age: 20-80Biological sex: AllType: ObservationalSponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Not listed

Status: Recruiting

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Randomized phase II trial aims to compare surgery with or without adjuvant chemotherapy in treating patients who are pathologically diagnosed as stage I lung adenocarcinoma with micropapillary component no less than 20%.

Participants needed: 460
Trial details
Phase: Phase 2Age: 19-70Biological sex: AllType: InterventionalSponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaUpdated: Dec 19, 2017Locations: 1
Eligibility criteria

Completely resected Stage I NSCLC as defined by the International Staging System [+10]

Do not meet the inclusion criteria [+10]